Price T Rowe Associates Inc Amedisys Inc Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Amedisys Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,777 shares of AMED stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,777
Previous 18,296 8.09%
Holding current value
$1.87 Million
Previous $1.66 Million 10.23%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$90.44 - $92.9 $133,941 - $137,584
1,481 Added 8.09%
19,777 $1.83 Million
Q4 2024

Feb 14, 2025
BUY
$83.78 - $97.71 $136,142 - $158,778
1,625 Added 9.75%
18,296 $1.66 Million
Q3 2024

Nov 14, 2024
BUY
$96.5 - $98.45 $24,704 - $25,203
256 Added 1.56%
16,671 $1.61 Million
Q2 2024

Aug 14, 2024
SELL
$90.4 - $96.77 $1.34 Million - $1.43 Million
-14,784 Reduced 47.39%
16,415 $1.51 Million
Q1 2024

May 15, 2024
BUY
$92.15 - $95.24 $23,498 - $24,286
255 Added 0.82%
31,199 $2.88 Million
Q4 2023

Feb 14, 2024
SELL
$91.15 - $95.89 $381,553 - $401,395
-4,186 Reduced 11.92%
30,944 $2.94 Million
Q3 2023

Nov 14, 2023
SELL
$89.84 - $94.08 $17.3 Million - $18.2 Million
-193,051 Reduced 84.6%
35,130 $3.28 Million
Q2 2023

Aug 14, 2023
SELL
$73.99 - $92.6 $1.63 Million - $2.04 Million
-21,982 Reduced 8.79%
228,181 $20.9 Million
Q1 2023

May 15, 2023
SELL
$69.79 - $100.33 $1.59 Million - $2.28 Million
-22,766 Reduced 8.34%
250,163 $18.4 Million
Q4 2022

Feb 14, 2023
SELL
$80.12 - $105.34 $5.87 Million - $7.72 Million
-73,274 Reduced 21.17%
272,929 $22.8 Million
Q3 2022

Nov 14, 2022
SELL
$96.79 - $131.14 $38.7 Million - $52.5 Million
-400,065 Reduced 53.61%
346,203 $33.5 Million
Q2 2022

Aug 15, 2022
SELL
$105.12 - $173.85 $17.7 Million - $29.3 Million
-168,412 Reduced 18.41%
746,268 $78.4 Million
Q1 2022

May 16, 2022
SELL
$124.79 - $178.09 $40.9 Million - $58.4 Million
-327,766 Reduced 26.38%
914,680 $158 Million
Q4 2021

Feb 14, 2022
SELL
$136.32 - $184.41 $4.08 Million - $5.52 Million
-29,940 Reduced 2.35%
1,242,446 $201 Million
Q3 2021

Nov 15, 2021
SELL
$149.1 - $270.32 $31.6 Million - $57.2 Million
-211,615 Reduced 14.26%
1,272,386 $190 Million
Q2 2021

Aug 16, 2021
SELL
$238.97 - $288.5 $14.3 Million - $17.3 Million
-59,893 Reduced 3.88%
1,484,001 $363 Million
Q1 2021

May 17, 2021
SELL
$236.62 - $314.16 $3.92 Million - $5.2 Million
-16,563 Reduced 1.06%
1,543,894 $409 Million
Q4 2020

Feb 16, 2021
BUY
$231.3 - $293.33 $361 Million - $458 Million
1,560,457 New
1,560,457 $458 Million

Others Institutions Holding AMED

# of Institutions
333
Shares Held
29.1M
Call Options Held
272K
Put Options Held
1.73M
View Full List

About AMEDISYS INC

AMED Quotes by TradingView
  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $3.08B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email